Success Metrics

Clinical Success Rate

100.0%

Based on 7 completed trials

Completion Rate

100%(7/7)

Active Trials

0(0%)

Results Posted

14%(1 trials)

Phase Distribution

Ph not_applicable

50%

Ph phase_4

25%

Ph phase_1

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

2(25.0%)

Phase 4Post-market surveillance

2(25.0%)

N/ANon-phased studies

4(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(7)

Other(1)

Detailed Status

Completed7

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (25.0%)

Phase 42 (25.0%)

N/A4 (50.0%)

Trials by Status

completed788%

unknown113%

Recent Activity

0 active trials

Showing 5 of 8

completedphase_1

Clinical Trials (8)

Showing 8 of 8 trials

NCT02232269Phase 1

Coffee Interaction With the Antihypertensive Drug Felodipine

Completed

NCT02744872Phase 4

Copenhagen Acute Renal Complications After Transplantations Study Group

Completed

NCT02327247Not Applicable

Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fasting Conditions

Completed

NCT02311530Not Applicable

Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fed Conditions

Completed

NCT00348686Phase 4

Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)

Completed

NCT00742066Not Applicable

Role of AT1-receptor Blockers in Insulin-induced Vasodilation.

Unknown

NCT00905333Phase 1

Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal

Completed

NCT01136863Not Applicable

Felodipine Event Reduction Study

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8